These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7799083)

  • 1. Evaluation of technetium-99m-sestamibi lung uptake: correlation with left ventricular function.
    Giubbini R; Campini R; Milan E; Zoccarato O; Orlandi C; Rossini P; Giannuzzi P; La Canna G; Galli M
    J Nucl Med; 1995 Jan; 36(1):58-63. PubMed ID: 7799083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative relationship of stress Tc-99m sestamibi lung uptake with resting Tl-201 lung uptake and with indices of left ventricular dysfunction and coronary artery disease.
    Patel GM; Hauser TH; Parker JA; Pinto DS; Sanders GP; Aepfelbacher FC; Koutkia P; Danias PG
    J Nucl Cardiol; 2004; 11(4):408-13. PubMed ID: 15295409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postexercise lung uptake of 99mTc-sestamibi determined by a new automatic technique: validation and application in detection of severe and extensive coronary artery disease and reduced left ventricular function.
    Bacher-Stier C; Sharir T; Kavanagh PB; Lewin HC; Friedman JD; Miranda R; Germano G; Berman DS
    J Nucl Med; 2000 Jul; 41(7):1190-7. PubMed ID: 10914908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical correlates of Tc-99m sestamibi lung uptake.
    Choy JB; Leslie WD
    J Nucl Cardiol; 2001; 8(6):639-44. PubMed ID: 11725259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitrate versus rest myocardial scintigraphy with technetium 99m-sestamibi: relationship of tracer uptake to regional left ventricular function and its significance in the detection of viable hibernating myocardium.
    Sciagrà R; Bisi G; Santoro GM; Rossi V; Fazzini PF
    Am J Card Imaging; 1995 Jul; 9(3):157-66. PubMed ID: 7549355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise and rest technetium-99m-tetrofosmin lung uptake: correlation with left ventricular ejection fraction in patients with coronary artery disease.
    Tsou SS; Sun SS; Kao A; Lin CC; Lee CC
    Jpn Heart J; 2002 Sep; 43(5):515-22. PubMed ID: 12452309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical correlation between increased lung to heart ratio of technetium-99m sestamibi and multivessel coronary artery disease.
    Kumar SP; Brewington SD; O'Brien KF; Movahed A
    Int J Cardiol; 2005 May; 101(2):219-22. PubMed ID: 15882667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the different biokinetics of sestamibi and tetrofosmin on the interpretation of myocardial perfusion imaging in daily practice.
    Hambÿe AS; Delsarte P; Vervaet AM
    Nucl Med Commun; 2007 May; 28(5):383-90. PubMed ID: 17414888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of reinjection thallium 201 and resting technetium 99m sestamibi tomographic images for the quantification of infarct size after acute myocardial infarction.
    Christian TF; O'Connor MK; Hopfenspirger MR; Gibbons RJ
    J Nucl Cardiol; 1994; 1(1):17-28. PubMed ID: 9420667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary uptake of technetium-99m-sestamibi induced by dipyridamole-based stress or exercise.
    Hurwitz GA; Ghali SK; Husni M; Slomka PJ; Mattar AG; Reid RH; Lefcoe NM
    J Nucl Med; 1998 Feb; 39(2):339-45. PubMed ID: 9476947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial uptake characteristics of three 99mTc-labeled tracers for myocardial perfusion imaging one hour after rest injection.
    Manka-Waluch A; Palmedo H; Reinhardt MJ; Joe AY; Manka C; Guhlke S; Biersack HJ; Bucerius J
    Ann Nucl Med; 2006 Dec; 20(10):663-70. PubMed ID: 17385304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technetium-99m sestamibi tomographic evaluation of residual ischemia after anterior myocardial infarction.
    Marcassa C; Galli M; Temporelli PL; Campini R; Orrego PS; Zoccarato O; Giordano A; Giannuzzi P
    J Am Coll Cardiol; 1995 Mar; 25(3):590-6. PubMed ID: 7860901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular function in patients with coronary artery disease assessed by gated tomographic myocardial perfusion images. Comparison with assessment by contrast ventriculography and first-pass radionuclide angiography.
    Williams KA; Taillon LA
    J Am Coll Cardiol; 1996 Jan; 27(1):173-81. PubMed ID: 8522692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative feasibility of separate or simultaneous rest thallium-201/stress technetium-99m-sestamibi dual-isotope myocardial perfusion SPECT.
    Kiat H; Germano G; Friedman J; Van Train K; Silagan G; Wang FP; Maddahi J; Berman D
    J Nucl Med; 1994 Apr; 35(4):542-8. PubMed ID: 8151372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased resting Tl-201 lung-to-heart ratio is associated with invasively determined measures of left ventricular dysfunction, extent of coronary artery disease, and resting myocardial perfusion abnormalities.
    Sanders GP; Pinto DS; Parker JA; Koutkia P; Aepfelbacher FC; Danias PG
    J Nucl Cardiol; 2003; 10(2):140-7. PubMed ID: 12673178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early post-stress pulmonary uptake of 99mTc tetrofosmin during exercise (SPECT) myocardial perfusion imaging: correlation with haemodynamic, perfusion and function parameters.
    Georgoulias P; Demakopoulos N; Kontos A; Xaplanteris P; Xydis K; Fezoylidis I
    Nucl Med Commun; 2006 Feb; 27(2):119-26. PubMed ID: 16404224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular cavity-to-myocardium count ratio in technetium-99m-sestamibi SPECT in the detection of resting left ventricular dysfunction.
    Sciagrà R; Bisi G; Buonamici P; Zerauschek F; Santoro GM; Meldolesi U; Fazzini PF; Pupi A
    J Nucl Med; 1997 May; 38(5):766-70. PubMed ID: 9170443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-pass radionuclide angiographic studies of left ventricular function with technetium-99m-teboroxime, technetium-99m-sestamibi and technetium-99m-DTPA.
    Williams KA; Taillon LA; Draho JM; Foisy MF
    J Nucl Med; 1993 Mar; 34(3):394-9. PubMed ID: 8382741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 99mTc-sestamibi: its clinical role as a viability agent.
    Marzullo P; Sambuceti G
    J Nucl Biol Med (1991); 1992; 36(3):259-66. PubMed ID: 1486119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The new 99mTc myocardial perfusion imaging agents: 99mTc-sestamibi and 99mTc-teboroxime.
    Berman DS; Kiat H; Maddahi J
    Circulation; 1991 Sep; 84(3 Suppl):I7-21. PubMed ID: 1832100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.